ACADIA Pharmaceuticals In... (ACAD)

NASDAQ: ACAD · Real-Time Price · USD

14.59

-0.01 (-0.07%)

At close: May 01, 2025, 3:59 PM

14.52

-0.48%

After-hours: May 01, 2025, 06:15 PM EDT

ACADIA Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	957.8M	726.44M	517.24M	484.14M	441.75M	339.08M	223.81M	124.9M	17.33M
Cost of Revenue	81.84M	45.73M	10.17M	19.14M	20.55M	19.6M	18.33M	13.06M	4.41M
Gross Profit	875.96M	680.71M	507.07M	465M	421.2M	319.48M	205.48M	111.84M	12.93M
Operating Income	230.79M	-73.38M	-223.6M	-170.44M	-286.59M	-246.54M	-247.44M	-292.41M	-272.81M
Interest Income	25.46M	17.23M	6.61M	591K	6.61M	11.16M	5.35M	4.13M	2.76M
Pretax Income	258.07M	-51.04M	-213.44M	-167.52M	-280.97M	-234.38M	-243.94M	-288.28M	-270.05M
Net Income	226.45M	-61.29M	-215.97M	-167.87M	-281.58M	-235.26M	-245.19M	-289.4M	-271.39M
Selling & General & Admin	488.43M	402.47M	369.09M	396.03M	388.66M	325.64M	265.76M	255.06M	186.46M
Research & Development	303.25M	351.62M	361.57M	239.41M	319.13M	240.38M	187.16M	149.19M	99.28M
Other Expenses	-146.51M	n/a	3.54M	2.33M	-997K	997K	-1.84M	3.98M	1.33M
Operating Expenses	645.16M	754.09M	730.66M	635.44M	707.79M	566.02M	452.92M	404.25M	285.74M
Interest Expense	n/a	n/a	6.61M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	9.4M	5.5M	41.8M	51.1M	38.3M	39.8M	15.6M	1.6M
Cost & Expenses	873.52M	799.82M	740.83M	654.58M	728.34M	585.62M	471.25M	417.31M	290.15M
Income Tax Expense	31.62M	10.25M	2.53M	351K	611K	876K	1.26M	1.12M	1.34M
Shares Outstanding (Basic)	165.72M	163.82M	161.68M	160.49M	157.33M	147.2M	126.58M	122.6M	115.86M
Shares Outstanding (Diluted)	166.36M	163.82M	161.68M	160.49M	157.33M	147.2M	126.58M	122.6M	115.86M
EPS (Basic)	1.37	-0.37	-1.34	-1.05	-1.79	-1.6	-1.94	-2.36	-2.34
EPS (Diluted)	1.36	-0.37	-1.34	-1.05	-1.79	-1.6	-1.94	-2.36	-2.34
EBITDA	100.16M	-67.83M	-221.57M	-167.09M	-286.59M	-243.78M	-244.44M	-289.7M	-270.99M
EBIT	84.28M	-73.38M	-223.6M	-170.44M	-286.59M	-246.54M	-247.44M	-292.41M	-272.81M
Depreciation & Amortization	15.88M	5.55M	2.03M	3.34M	2.93M	2.77M	3M	2.71M	1.83M